5860
S. Chirachanchai et al. / Tetrahedron 65 (2009) 5855–5861
C22H29NO2: C, 77.84; H, 8.61; N, 4.13; O, 9.42%. Found: C, 77.63; H,
8.40; N, 4.12%. Crystal data for 3: C22H29NO2, M¼339.48, triclinic,
Compound 8: 65% yield; mp¼219–220 ꢁC; FTIR (KBr, cmꢀ1):
1473 (s, tri-substituted benzene), 1209 (vs, C–N stretching), 1051 (s,
C–O–C); 1H NMR (400 MHz, CDCl3, ppm): dH 1.97 (4H, m, CH2), 2.01
(8H, m, O–CH2–CH2), 2.22–2.34 ((24H, s, Ar–CH3) and (16H, m,
CH2)), 2.46 (2H, m, CH), 3.56 (8H, s, Ar–CH2–N), 4.02 (8H, m, O–CH2–
CH2), 6.85 (4H, s, Ar–H), 6.92 (4H, s, Ar–H). MALDI-TOF MS: m/z
844.55 (MþHþ). Anal. Calcd for C56H78N2O4: C, 79.76; H, 9.32; N,
3.32; O, 7.59%. Found: C, 77.27; H, 9.03; N, 3.39%. Crystal data for 8:
C56H78N2O4, M¼843.24, triclinic, a¼10.1109(5) Å, b¼11.2701(5) Å,
a¼9.2230(3) Å, b¼10.2768(3) Å, c¼11.4606(4) Å,
a
¼111.6953(10)ꢁ,
b
¼95.7124(11)ꢁ,
g
¼99.7462(10)ꢁ, V¼979.04(5) Å3, T¼296 K, space
group P1 (no. 2), Z¼2,
m
(Mo K
a
)¼0.726 cmꢀ1, 3491 reflections
measured, 599 unique (Rint¼0.025), which were used in all calcu-
lations. The final R1¼0.0336 and wR2¼0.0999.
Compound 4: 76% yield; mp¼171–173 ꢁC; FTIR (KBr, cmꢀ1):
1481 (vs, tri-substituted benzene), 1213 (vs, C–N stretching), 1076
(vs, C–O–C); 1H NMR (400 MHz, CDCl3, ppm): dH 1.96 (3H, s, N–
CH3), 2.00 (4H, t, O–CH2–CH2, J¼7.92 Hz), 2.25 (12H, s, Ar–CH3), 3.55
(4H, s, Ar–CH2–N), 4.01 (4H, t, O–CH2–CH2, J¼7.92 Hz), 6.85 (2H, s,
Ar–H), 6.92 (2H, s, Ar–H). MALDI-TOF MS: m/z 354.13 (MþHþ). Anal.
Calcd for C23H31NO2: C, 78.15; H, 8.84; N, 3.96; O, 9.05%. Found: C,
77.35; H, 8.82; N, 3.88%. Crystal data for 4: C23H31NO2, M¼353.50,
monoclinic, a¼8.8186(3) Å, b¼8.9144(3) Å, c¼12.8234(4) Å,
c¼11.9581(6) Å,
a
¼104.883(3)ꢁ,
b
¼90.099(3)ꢁ,
g
¼109.335(3)ꢁ,
V¼1237.01(10) Å3, T¼213 K, space group P1 (no. 2), Z¼1,
m(Cu
Ka
)¼5.381 cmꢀ1
, 12,796 reflections measured, 4399 unique
(Rint¼0.089), which were used in all calculations. The final
R1¼0.1060 and wR2¼0.2719.
4.3.4. Compound 9
b
¼92.9630(17)ꢁ, V¼1006.73(5) Å3, T¼213 K, space group P21 (no.
Compound 9 was achieved by using the same procedures as 7,
but using ditosylated diethylene (0.414 g, 1 mmol) instead of 1,3-
bis(tosyloxy)propane (0.385 g, 1 mmol) as the starting compound.
Compound 9: 90% yield; mp¼223–225 ꢁC; FTIR (KBr, cmꢀ1):
3312 (w, –NH–), 1484 (vs, tri-substituted benzene), 1364 (s,
O]S]O), 1221 (s, C–N stretching), 1177 (vs, O]S]O); 1H NMR
(400 MHz, CDCl3, ppm): dH 0.70 (4H, m, CH2), 0.95 (4H, m, CH2), 1.15
(2H, m, CH2), 1.68 (2H, m, CH2), 2.20 (3H, s, Ar–CH3), 2.32 (3H, s,
Ar–CH3), 2.38 (3H, s, S–Ar–CH3), 2.69 (1H, m, CH), 3.52 (2H, t, CH2–
CH2–O, J¼3.69 Hz), 3.88 (2H, s, Ar–CH2–N), 4.02 (2H, t, S–O–CH2,
J¼3.84 Hz), 6.72 (1H, s, Ar–H), 6.85 (1H, s, Ar–H), 7.18 (2H, d, S–Ar–
H, J¼1.59 Hz), 7.30 (2H, d, S–Ar–H, J¼1.59 Hz), 7.70 (4H, m, S–Ar–H).
FAB MS: m/z 234.2. Anal. Calcd for C22H31NSO4: C, 65.15; H, 7.70; N,
3.45; O, 15.78; S, 7.91%. Found: C, 64.74; H, 7.69; N, 3.36; S, 7.05%.
Crystal data for 9: C22H31NSO4, M¼405.55, monoclinic,
4), Z¼2,
m
(Cu K
a
)¼5.708 cmꢀ1, 10,556 reflections measured, 3577
unique (Rint¼0.068), which were used in all calculations. The final
R1¼0.1097 and wR2¼0.3422.
Compound 5: 70% yield; mp 90–91 ꢁC; FTIR (KBr, cmꢀ1): 1481
(vs, tri-substituted benzene), 1221 (vs, C–N stretching), 1053 (s, C–
O–C); 1H NMR (400 MHz, CDCl3, ppm): dH 2.10 (3H, s, N–CH3), 2.30
(12H, s, Ar–CH3), 3.79 (4H, s, Ar–CH2–N), 3.95 (4H, t, CH2–O–CH2,
J¼3.52 Hz), 4.07 (4H, t, Ar–O–CH2, J¼3.52 Hz), 6.84 (2H, s, Ar–H),
6.93 (2H, s, Ar–H); 13C NMR (100 MHz, CDCl3, ppm): dC 16.32, 20.79,
39.76, 58.03, 72.06, 77.06, 130.84, 131.01, 131.28, 131.33, 132.44,
154.41. MALDI-TOF MS: m/z 370.32 (MþHþ). Anal. Calcd for
C23H31NO3: C, 74.47; H, 8.40; N, 3.79; O, 13.34%. Found: C, 74.47; H,
8.41; N, 3.87%.
Compound 6: 80% yield; mp¼97–100 ꢁC; FTIR (KBr, cmꢀ1): 1489
(vs, tri-substituted benzene), 1209 (vs, C–N stretching), 1057 (s, C–
O–C); 1H NMR (400 MHz, CDCl3, ppm): dH 2.17 (3H, s, N–CH3), 2.24
(12H, s, Ar–CH3), 3.71 (4H, s, Ar–CH2–N), 3.80–3.83 (8H, m, CH2–O–
CH2), 3.95–3.99 (4H, m, Ar–O–CH2), 6.84 (2H, s, Ar–H), 7.12 (2H, s,
Ar–H); 13C NMR (100 MHz, CDCl3, ppm): dC 16.29, 20.76, 41.96,
55.25, 70.81, 72.37, 77.00, 128.96, 130.19, 130.25, 132.10, 133.15,
153.84. MALDI-TOF MS: m/z 414.26 (MþHþ). Anal. Calcd for
C25H35NO4: C, 72.61; H, 8.53; N, 3.39; O, 15.47%. Found: C, 72.41; H,
8.38; N, 3.38%. Crystal data for 6: C25H35NO4, M¼413.56, ortho-
a¼25.1142(6) Å, b¼10.0918(3) Å, c¼16.3733(4) Å,
b
¼94.3394(15)ꢁ,
V¼4137.88(17) Å3, T¼123 K, space group C2/c (no. 15), Z¼8,
m(Cu
K
a
)¼16.164 cmꢀ1
, 20,057 reflections measured, 3777 unique
(Rint¼0.104), which were used in all calculations. The final
R1¼0.0885 and wR2¼0.2845.
4.3.5. [1þ1] Macrocycle 10
[1þ1] Macrocycle, 10 was achieved by using the same pro-
cedures as 6, but using 2 (0.367 g, 1 mmol) instead of 1 (0.299 g,
1 mmol) as the starting compound. The crude product was
recrystallized by the mixed solvent of isopropanol and chloroform
(3:2, v/v).
rhombic,
a¼18.0895(4) Å,
b¼8.9394(2) Å,
c¼14.4691(3) Å,
V¼2339.79(9) Å3, T¼296 K, space group Pna21 (no. 33), Z¼4,
m(Mo
K
a
)¼0.783 cmꢀ1
,
7677 reflections measured, 388 unique
(Rint¼0.019), which were used in all calculations. The final
Compound 10: 79% yield; mp¼115–118 ꢁC; FTIR (KBr, cmꢀ1):
1479 (s, tri-substituted benzene), 1209 (vs, C–N stretching), 1058 (s,
C–O–C); 1H NMR (400 MHz, CDCl3, ppm): dH 1.12 (2H, m, CH2), 1.36
(2H, m, CH2), 1.58 (2H, m, CH2), 1.75 (2H, m, CH2), 1.98 (2H, m, CH2),
2.22 (6H, s, Ar–CH3), 2.26 (6H, s, Ar–CH3), 2.44 (1H, m, CH), 3.75 (4H,
s, Ar–O–CH2–CH2–O–CH2), 3.78 (4H, s, Ar–CH2–N), 3.82 (4H, m, Ar–
O–CH2–CH2), 3.92 (4H, m, Ar–O–CH2), 6.79 (2H, s, Ar–H), 7.25 (2H, s,
Ar–H); 13C NMR (100 MHz, CDCl3, ppm): dC 16.01, 20.53, 24.96,
25.99, 28.01, 47.47, 58.78, 70.25, 72.14, 77.00, 128.88, 129.77, 130.57,
130.69, 133.05, 153.61. MALDI-TOF MS: m/z 483.21 (MþHþ). Anal.
Calcd for C30H43NO4: C, 74.81; H, 9.00; N, 2.91; O, 13.29%. Found: C,
71.23; H, 8.57; N, 4.28%. Crystal data for 10: C30H43NO4, M¼481.67, tri-
R1¼0.0290 and wR2¼0.0804.
4.3.3. [2þ2] Macrocycles (7 and 8)
[2þ2] Macrocycles (7 and 8) were prepared from the same
procedures as 3 and 4, respectively, but using 2 (0.367 g, 1 mmol)
instead of 1 (0.299 g, 1 mmol) as the starting compound. The crude
product was recrystallized by the mixed solvent of isopropanol and
chloroform (3:2, v/v).
Compound 7: 68% yield; mp¼206–207 ꢁC; FTIR (KBr, cmꢀ1):
1481 (vs, tri-substituted benzene), 1209 (vs, C–N stretching), 1056
(s, C–O–C); 1H NMR (400 MHz, CDCl3, ppm): dH 1.26 (4H, m, CH2),
1.90 (4H, m, CH2–CH2–CH2), 2.20–2.27 ((24H, s, Ar–CH3) and (16H,
m, CH2)), 2.44 (2H, m, CH), 3.66 (8H, s, Ar–CH2–N), 3.88 (8H, t, Ar–
O–CH2, J¼6.75 Hz), 6.82 (4H, s, Ar–H), 7.33 (4H, s, Ar–H). FAB MS: m/z
408.4 (MþHþ). Anal. Calcd for C54H74N2O4: C, 79.56; H, 9.15; N, 3.44;
O, 7.85%. Found: C, 77.27; H, 9.01; N, 3.99%. Crystal data for 7:
C54H74N2O4, M¼815.19, triclinic, a¼9.8551(3) Å, b¼9.8809(4) Å,
clinic, a¼10.2934(5) Å, b¼11.0830(5) Å, c¼13.8177(6) Å,
a
¼70.900(3)ꢁ,
b
¼79.973(3)ꢁ,
g
¼74.412(3)ꢁ, V¼1428.34(11) Å3, T¼273 K, space group
P1 (no. 2), Z¼2,
m
(Cu K
a
)¼5.771 cmꢀ1, 14,840 reflections measured,
5091 unique (Rint¼0.392), which were used in all calculations. The
final R1¼0.1699 and wR2¼0.5297.
c¼13.7754(4) Å,
a
¼90.004(2)ꢁ,
b
¼99.8559(18)ꢁ,
g
¼115.8896(16)ꢁ,
Acknowledgements
V¼1184.74(7) Å3, T¼213 K, space group P1 (no. 2), Z¼1,
m(Cu
K
a
)¼5.464 cmꢀ1
,
12,516 reflections measured, 4229 unique
The authors acknowledge the financial support from the Thai-
land Research Fund (Royal Golden Jubilee Ph.D. Program, Grant No.
PHD/0068/2548 and Research Scholar Award, Grant No.
(Rint¼0.102), which were used in all calculations. The final R1¼0.1297
and wR2¼0.4090.